Author information:
(1)1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard 
Medical School; 2Department of Pathology, Massachusetts General Hospital Cancer 
Center, Boston; 3Broad Institute of MIT and Harvard; 4Harvard-MIT Division of 
Health Sciences and Technology, Massachusetts Institute of Technology (MIT), 
Cambridge, Massachusetts; 5Department of Dermatology, University Hospital, West 
German Cancer Center, University Duisburg-Essen, Essen; 6German Cancer 
Consortium (DKTK); 7Department of Dermatology, Heidelberg University Hospital, 
Heidelberg; 8Department of Dermatology and Allergy, Hannover Medical School, 
Hannover; 9Department of Dermatology, University of Wuerzburg, Wuerzburg; 
10Department of Dermatology, Venerology and Allergology, University of 
Schleswig-Holstein Hospital, Kiel; 11Department of Dermatology and Allergology, 
Ludwig-Maximilian University, Munich; 12Department of Dermatology, Venerology 
and Allergy, Charité Universitätsmedizin Berlin, Humboldt University, Berlin; 
13Department of Dermatology, University of Mainz, Mainz; 14University Medical 
Center, University of Tübingen, Tübingen, Germany; 15Department of Genome 
Sciences, University of Washington, Seattle, Washington; 16Department of 
Dermatology, University Hospital Zurich, Zurich, Switzerland; and 17First 
Department of Medicine, Medical School, University of Athens, Athens, Greece.